These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 22167275)

  • 1. Long-term outcome and intervention of urea cycle disorders in Japan.
    Kido J; Nakamura K; Mitsubuchi H; Ohura T; Takayanagi M; Matsuo M; Yoshino M; Shigematsu Y; Yorifuji T; Kasahara M; Horikawa R; Endo F
    J Inherit Metab Dis; 2012 Sep; 35(5):777-85. PubMed ID: 22167275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan.
    Uchino T; Endo F; Matsuda I
    J Inherit Metab Dis; 1998; 21 Suppl 1():151-9. PubMed ID: 9686352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of liver transplantation in urea cycle disorders: Report from a nationwide study in Japan.
    Kido J; Matsumoto S; Häberle J; Inomata Y; Kasahara M; Sakamoto S; Horikawa R; Tanemura A; Okajima H; Suzuki T; Nakamura K
    J Inherit Metab Dis; 2021 Nov; 44(6):1311-1322. PubMed ID: 34232532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical manifestations and growth of patients with urea cycle disorders in Japan.
    Nakamura K; Kido J; Matsumoto S; Mitsubuchi H; Endo F
    J Hum Genet; 2016 Jul; 61(7):613-6. PubMed ID: 26935171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of urea cycle disorders: Report from a nationwide study in Japan.
    Kido J; Matsumoto S; Häberle J; Nakajima Y; Wada Y; Mochizuki N; Murayama K; Lee T; Mochizuki H; Watanabe Y; Horikawa R; Kasahara M; Nakamura K
    J Inherit Metab Dis; 2021 Jul; 44(4):826-837. PubMed ID: 33840128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early liver transplantation in neonatal-onset and moderate urea cycle disorders may lead to normal neurodevelopment.
    Kido J; Matsumoto S; Mitsubuchi H; Endo F; Nakamura K
    Metab Brain Dis; 2018 Oct; 33(5):1517-1523. PubMed ID: 29948653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of urea cycle disorder in Japan.
    Nakamura K; Kido J; Mitsubuchi H; Endo F
    Pediatr Int; 2014 Aug; 56(4):506-9. PubMed ID: 25039902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal treatment of ornithine transcarbamylase deficiency.
    Wilnai Y; Blumenfeld YJ; Cusmano K; Hintz SR; Alcorn D; Benitz WE; Berquist WE; Bernstein JA; Castillo RO; Concepcion W; Cowan TM; Cox KL; Lyell DJ; Esquivel CO; Homeyer M; Hudgins L; Hurwitz M; Palma JP; Schelley S; Akula VP; Summar ML; Enns GM
    Mol Genet Metab; 2018 Mar; 123(3):297-300. PubMed ID: 29396029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical course of 63 patients with neonatal onset urea cycle disorders in the years 2001-2013.
    Unsinn C; Das A; Valayannopoulos V; Thimm E; Beblo S; Burlina A; Konstantopoulou V; Mayorandan S; de Lonlay P; Rennecke J; Derbinski J; Hoffmann GF; Häberle J
    Orphanet J Rare Dis; 2016 Aug; 11(1):116. PubMed ID: 27538463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-sectional observational study of 208 patients with non-classical urea cycle disorders.
    Rüegger CM; Lindner M; Ballhausen D; Baumgartner MR; Beblo S; Das A; Gautschi M; Glahn EM; Grünert SC; Hennermann J; Hochuli M; Huemer M; Karall D; Kölker S; Lachmann RH; Lotz-Havla A; Möslinger D; Nuoffer JM; Plecko B; Rutsch F; Santer R; Spiekerkoetter U; Staufner C; Stricker T; Wijburg FA; Williams M; Burgard P; Häberle J
    J Inherit Metab Dis; 2014 Jan; 37(1):21-30. PubMed ID: 23780642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of orotic acid measurement in routine newborn screening for urea cycle disorders.
    Staretz-Chacham O; Daas S; Ulanovsky I; Blau A; Rostami N; Saraf-Levy T; Abu Salah N; Anikster Y; Banne E; Dar D; Dumin E; Fattal-Valevski A; Falik-Zaccai T; Hershkovitz E; Josefsberg S; Khammash H; Keidar R; Korman SH; Landau Y; Lerman-Sagie T; Mandel D; Mandel H; Marom R; Morag I; Nadir E; Yosha-Orpaz N; Pode-Shakked B; Pras E; Reznik-Wolf H; Saada A; Segel R; Shaag A; Shaul Lotan N; Spiegel R; Tal G; Vaisid T; Zeharia A; Almashanu S
    J Inherit Metab Dis; 2021 May; 44(3):606-617. PubMed ID: 33190319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual cause of general malaise: a young woman with ornithine transcarbamylase deficiency.
    Singh S; Pal S; Dubrey SW
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of arginine treatment on nutrition, growth and urea cycle function in seven Japanese boys with late-onset ornithine transcarbamylase deficiency.
    Nagasaka H; Yorifuji T; Murayama K; Kubota M; Kurokawa K; Murakami T; Kanazawa M; Takatani T; Ogawa A; Ogawa E; Yamamoto S; Adachi M; Kobayashi K; Takayanagi M
    Eur J Pediatr; 2006 Sep; 165(9):618-24. PubMed ID: 16703326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency.
    Imoto K; Tanaka M; Goya T; Aoyagi T; Takahashi M; Kurokawa M; Tashiro S; Kato M; Kohjima M; Ogawa Y
    BMC Gastroenterol; 2022 Mar; 22(1):144. PubMed ID: 35346058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Application of Next-Generation Sequencing (NGS) in Neonatal-Onset Urea Cycle Disorders (UCDs): Clinical Course, Metabolomic Profiling, and Genetic Findings in Nine Chinese Hyperammonemia Patients.
    Zhou Q; Huang H; Ma L; Zhu T
    Biomed Res Int; 2020; 2020():5690915. PubMed ID: 32934962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal factors related to survival and intellectual and developmental outcome of patients with early-onset urea cycle disorders.
    Pontoizeau C; Roda C; Arnoux JB; Vignolo-Diard P; Brassier A; Habarou F; Barbier V; Grisel C; Abi-Warde MT; Boddaert N; Kuster A; Servais A; Kaminska A; Hennequin C; Dupic L; Lesage F; Touati G; Valayannopoulos V; Chadefaux-Vekemans B; Oualha M; Eisermann M; Ottolenghi C; de Lonlay P
    Mol Genet Metab; 2020 Jun; 130(2):110-117. PubMed ID: 32273051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citrulline for urea cycle disorders in Japan.
    Tanaka K; Nakamura K; Matsumoto S; Kido J; Mitsubuchi H; Ohura T; Endo F
    Pediatr Int; 2017 Apr; 59(4):422-426. PubMed ID: 27613354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of neonatal onset proximal versus distal urea cycle disorders do not differ.
    Ah Mew N; Krivitzky L; McCarter R; Batshaw M; Tuchman M;
    J Pediatr; 2013 Feb; 162(2):324-9.e1. PubMed ID: 22901741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycerol phenylbutyrate efficacy and safety from an open label study in pediatric patients under 2 months of age with urea cycle disorders.
    Longo N; Diaz GA; Lichter-Konecki U; Schulze A; Inbar-Feigenberg M; Conway RL; Bannick AA; McCandless SE; Zori R; Hainline B; Ah Mew N; Canavan C; Vescio T; Kok T; Porter MH; Berry SA
    Mol Genet Metab; 2021 Jan; 132(1):19-26. PubMed ID: 33388234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes in Ornithine Transcarbamylase deficiency: a series of 90 patients.
    Brassier A; Gobin S; Arnoux JB; Valayannopoulos V; Habarou F; Kossorotoff M; Servais A; Barbier V; Dubois S; Touati G; Barouki R; Lesage F; Dupic L; Bonnefont JP; Ottolenghi C; De Lonlay P
    Orphanet J Rare Dis; 2015 May; 10():58. PubMed ID: 25958381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.